Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence, J. Invest. Dermatol, vol.134, pp.43-50, 2014. ,
Merkel cell carcinoma: current US incidence and projected increases based on changing demographics, J. Am. Acad. Dermatol, vol.78, pp.457-463, 2018. ,
Epidemiology of primary Merkel cell carcinoma in the United States, J. Am. Acad. Dermatol, vol.49, pp.832-841, 2003. ,
Clonal integration of a polyomavirus in human Merkel cell carcinoma, Science, vol.319, pp.1096-1100, 2008. ,
Large T and small T antigens of Merkel cell polyomavirus, Curr. Opin. Virol, vol.11, pp.38-43, 2015. ,
Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases, Br. J. Dermatol, vol.162, pp.59-63, 2010. ,
Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer, Med. Microbiol. Immunol, vol.201, pp.17-23, 2012. ,
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.16272-16277, 2008. ,
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors, Int. J. Cancer, vol.125, pp.1243-1249, 2009. ,
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator, J. Clin. Invest, vol.121, pp.3623-3634, 2011. ,
, Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy, vol.7, pp.3403-3415, 2016.
Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system, Ann. Surg. Oncol, vol.23, pp.3564-3571, 2016. ,
Immune checkpoint inhibitors and beyond: an overview of immunebased therapies in merkel cell carcinoma, Am. J. Clin. Dermatol, vol.78, pp.2-17, 2019. ,
Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology, J. Natl. Compr. Cancer Netw, vol.16, pp.742-774, 2018. ,
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial, Lancet Oncol, vol.17, pp.30364-30367, 2016. ,
Durable tumor regression and overall survival in patients with advanced merkel cell carcinoma receiving pembrolizumab as first-line therapy, J. Clin. Oncol, vol.37, pp.693-702, 2019. ,
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study, Am. J. Clin. Pathol, vol.142, pp.452-458, 2014. ,
Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study, Clin. Cancer Res, vol.18, pp.2872-2881, 2012. ,
Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival, Cancer Immunol Res, vol.5, pp.137-147, 2017. ,
Merkel cell polyomavirus-specific CD8 + and CD4 ,
, + T-cell responses identified in Merkel cell carcinomas and blood, vol.17, pp.6671-6680, 2011.
Development of a DNA vaccine targeting Merkel cell polyomavirus, Vaccine, vol.30, pp.1322-1329, 2012. ,
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors, Clin. Cancer Res, vol.20, pp.1768-1778, 2014. ,
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I, Cancer Immunol. Res, vol.2, pp.27-36, 2014. ,
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy, J. Immunother. Cancer, vol.6, 2018. ,
Mutation analysis of P73 and TP53 in Merkel cell carcinoma, Br. J. Cancer, vol.82, pp.823-826, 2000. ,
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur. J. Immunol, vol.31, 2001. ,
Guidelines for the diagnosis and treatment of Merkel cell carcinoma -cutaneous oncology group of the french society of dermatology, Eur. J. Dermatol, vol.22, pp.375-379, 2012. ,
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage, J. Invest. Dermatol, vol.133, pp.642-646, 2013. ,
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas, Mod. Pathol, vol.32, pp.499-510, 2019. ,
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma, Br. J. Dermatol, vol.174, pp.813-822, 2016. ,
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991. ,
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol. Immunother, vol.50, pp.134-140, 2001. ,
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptidepulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000. ,
Establishment and characterization of a neuroendocrine skin carcinoma cell line, Lab. Invest, vol.56, pp.302-312, 1987. ,
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice, J. Virol. Meth, vol.187, pp.6-14, 2013. ,
Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma, Int. J. Cancer, vol.101, pp.137-145, 2002. ,
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens, J. Virol, vol.84, pp.7064-7072, 2010. ,
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens, J. Invest. Dermatol, vol.133, pp.2453-2460, 2013. ,
A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J. Exp. Med, vol.191, pp.1617-1624, 2000. ,
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996. ,
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, J. Exp. Med, vol.205, pp.2673-2682, 2008. ,
Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes, Methods, vol.12, pp.125-142, 1997. ,
Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA, J. Exp. Med, vol.181, pp.2085-2095, 1995. ,
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C, J. Exp. Med, vol.176, pp.937-950, 1992. ,
A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming, J. Immunol, vol.192, pp.1962-1971, 2014. ,
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA, Nat. Commun, vol.9, 2018. ,
Targeting merkel cell carcinoma by engineered T cells specific to T-antigens of merkel cell polyomavirus, Clin. Cancer Res, vol.24, pp.3644-3655, 2018. ,
Molecular and cellular insights into T cell exhaustion, Nat. Rev. Immunol, vol.15, pp.486-499, 2015. ,
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses, J. Invest. Dermatol, vol.133, pp.1879-1889, 2013. ,
The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma, Cancer Res, vol.75, pp.3720-3727, 2015. ,